Pathologie prédictive des lymphomes [Predictive pathology of lymphomas].

Détails

ID Serval
serval:BIB_073E1E48C018
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Pathologie prédictive des lymphomes [Predictive pathology of lymphomas].
Périodique
Revue Médicale Suisse
Auteur⸱e⸱s
Gréloz V., Rausch T., McKee T.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
2009
Volume
5
Numéro
211
Pages
1509-1512
Langue
français
Résumé
The predictive pathology in the diagnosis of B-cell lymphomas is a field in evolution. As our understanding of these tumours progresses so does our ability to predict their evolution. This is true not only in the wider and traditional sense where a given marker identifies a group of tumors with a better or worse prognosis but also with reference to specific patients. Here the development of new therapeutic agents whose activity depends on the expression within the tumour of specific proteins has begun to bring the long awaited era of "personalised therapy" a little closer to reality.
Mots-clé
Antineoplastic Agents/therapeutic use, Humans, Lymphoma, B-Cell/drug therapy, Lymphoma, B-Cell/pathology, Prognosis
Pubmed
Création de la notice
30/09/2011 15:28
Dernière modification de la notice
20/08/2019 12:29
Données d'usage